Centurion 2000 Central Station Arrhythmia Patient Monitoring System

No FDA recalls found in the data synced 22 Oct 2026.

510(k) Number

K002604 ↗

FDA Product Code

DSI

Device Class

Class II

Regulation

21 CFR Part 870.1025

Advisory Committee

Cardiovascular

FDA Decision

SESE Substantially Equivalent

• Omega 5000

  Class II

  FDA 510(k) K833978 Active Cleared 9 Mar 1984

• Omni-Trak (Patient Monitor)

  Class II

  FDA 510(k) K890817 Active Cleared 10 Aug 1989

• Invivo Pulse Oximeter, Model 4500

  Class II

  FDA 510(k) K864730 Active Cleared 6 May 1987

• Millennia 3500 Series Monitor with Anthesthetic Agent

  Class II

  FDA 510(k) K974581 Active Cleared 28 Oct 1998

• Integrated Patient Monitoring System

  Class II

  FDA 510(k) K041918 Active Cleared 15 Oct 2004

• Omni-Central Station Monitor

  Class II

  FDA 510(k) K936051 Active Cleared 6 Jul 1994

See all devices from Invivo Research, Inc. →

• What is the Centurion 2000 Central Station Arrhythmia Patient Monitoring System used for?

  The Centurion 2000 is designed for general hospital or clinical use by medical professionals. It provides centralized display, storage and recording of patient vital sign and waveform data that is being monitored in cardiovascular settings.

• How is the Centurion 2000 system supplied and what is its regulatory status?

  The system is supplied as a Class 2 device with FDA 510(k) clearance K002604, determined to be substantially equivalent. It is manufactured by Invivo Research, Inc. and is designed for use in cardiovascular settings.

• What are the key features of the Centurion 2000 monitoring system?

  The Centurion 2000 provides centralized display, storage and recording of patient vital sign and waveform data. It is intended for general hospital or clinical use by medical professionals and is specifically designed for cardiovascular settings.

• Who manufactures the Centurion 2000 Central Station Arrhythmia Patient Monitoring System?

  The Centurion 2000 is manufactured by Invivo Research, Inc., located in Orlando, Florida. The company is responsible for the production and distribution of this monitoring system for clinical use.